Vermillion Posts $345K in Q4 Revenues

Company CEO Gail Page said Vermillion expects to launch its OVA1 triage ovarian cancer test in at least one country outside the US by mid-year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories